Categories

Share:

New Corporate Brochure

February 17, 2020

To make your choice easier and faster 4bases’ company and product information are gathered in the new brochure

Share:

Categories

More Posts

4bases is happy to announce a collaboration agreement with Meridian Bioscience

Ambient-stable NGS workflows, enabled by Meridian’s lyophilization expertise, expand global access to 4bases’ KaryoSolver™, a platform for rapid structural variant analysis. The Life Science division

4bases’ Paper of The Month – April 2026 – ESC Consensus on Genetic Counselling Implementation in Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM) is a heterogeneous disease caused by genetic, environmental, or combined factors. April’s “4bases Paper of the Month” reports about a clinical consensus

4bases’ Paper of The Month – March 2026 – Next-Generation Sequencing in Oncology: From Genomic Profiling to Real-Time Disease Management

A comprehensive description of the impact that Next-Generation Sequencing is having on cancer diagnosis and treatment has been published recently on the MDPI open access

4bases’ Paper of The Month – February 2026 – Germline DNA Repair Defects Define a High-Risk Subset of Multiple Myeloma

A newly published, large case–control study shows that germline mutations in specific DNA damage response genes significantly increase the risk of developing multiple myeloma. The article appeared in